TADLIQ (Tadalafil)
TADLIQ is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability. Studies establishing…
Medication Brand Names Beginning with ‘T’, Page 19
Tafinlar (Dabrafenib)
TAFINLAR is a kinase inhibitor indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved…
Tafluprost (Tafluprost Opthalmic)
Tafluprost ophthalmic solution, 0.0015% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Tafluprost ophthalmic…
Tafluprost
Tafluprost ophthalmic solution 0.0015% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Tafluprost ophthalmic…
Tafluprost
NDC 0781-6184-87. Tafluprost Ophthalmic Solution 0.0015%. Single-Use Containers. Preservative-Free. Sterile. For Topical Application in the Eye. REFRIGERATE (2° to 8°C or 36° to 46°F)…